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Summary: Enzymes from animal sources are frequently used for quality control of enzyme activity determinations
in clinical chemistry. For this purpose they should be very similar to human enzymes. It is shown that preparations
of enzymes of diagnostic interest from human and porcine organs, purified in exactly the same way, have very similar
pH-optima and apparent Michaelis constants for their substrates.
Isolierung, pHOptima und apparente Michaelis-Konstanten hoch gereinigter Enzyme
aus humanem und tierischem Gewebe.
Vergleich humaner und tierischer Enzyme, I. Mitteilung
Zusammenfassung: Enzympräparate tierischen Ursprungs werden häufig für den Einsatz in Qualitätskontrollproben
für die klinische Chemie verwendet. Zu diesem Zweck sollten sie humanen Enzymen möglichst ähnlich sein. Es wird
gezeigt, daß Enzyme von diagnostischem Interesse, welche aus Human- und aus Schweine-Organen auf gleiche Weise
hoch gereinigt wurden, sehr ähnliche pH-Optima und apparente Michaelis-Konstanten gegenüber ihren Substraten auf-
weisen.
Introduction
For quality control in determinations of the activity of
enzymes in Clinical Chemistry materials with enhanced
enzyme content are frequently needed. Patients' sera
with an endogenous enhancement of these enzymes are
not available in sufficient quantities and may show
stability problems, especially on shipment for inter-
laboratory surveys. Materials, to which enzyme prepara-
tions have been added, are preferable for routine use.
These enzymes should be as closely related to those in
the patients' sera as possible in any aspect of routine
analytical importance. Therefore, isolation of such enzy-
mes from human organs would be a good choice, but is
restricted by ethical reasons. Only two human organs
are easily available, blood or blood fractions and
placenta. Enzyme preparations useful for quality
control and standardization purposes, have been
obtained from both these sources, e. g. aspartate
aminotransferase ( ,-Aspartate: 2-oxoglutarate amiho-
transferase, EC 2.6.1.1) (1) and alkaline phosphatase
(orthophosphoric monoester phosphohydrolase,
EC 3.1.3.1) (2). But most of the enzymes needed can-
not be adequately prepared from these materials.
It is therefore the intention of this study and of two
following papers (3,4) to recheck dissimilarities of
analytical interest between human and mammalian
enzymes. Preliminary reports on this work were given
at the 1st European Congress on Clinical Chemistry in
Munich 1974 (5, 6) and at the 9th International Con-
gress of Clinical Chemistry in Toronto 1975 (7).
Nowdays, all enzymes of diagnostic interest are ex-
tensively studied with respect to their chemical, catalytic
and physical properties. The data are accumulated in
different hand-books, e. g. (8,9, 10,11). Also, there is
much published data on the comparison of enzymes
and isoenzymes (12,13) from different animal sources,
including more limited information on enzymes from
human organs. Some dissimilarities in catalytic properties,
which are apparent from different publications may be
due mainly to differences in the isolation procedures,
the state of purity and the assay conditions and not to
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basic differences in catalytic properties. We therefore
decided to isolate these enzymes from the same organs,
using the same isolation steps and to perform the assays
simultaneously in exactly the same assay media.
The characteristics of the isolated enzymes that were
used for comparison were pH-optima and apparent
Michaelis constants. As cited e. g. in 1. c. (14) apparent
Michaelis constants of multi component reactions
depend on the assay conditions used (e. g. temperature,
substrate concentrations, salt content, activators, inhibi-
tors, pH, etc.). We therefore chose methodologies of
broader international use. It should be noted that the
values given are only found for these special conditions,
whereas our main concern is to show those similarities
found between the human and animal enzymes, which
should also be valid for other assay media.
Materials and Methods
All enzymes, coenzymes and most substrates used were products
of Boehringer Mannheim GmbH. Determinations of enzyme
activities were performed with Test-Combinations of Boehringer
Mannheim GmbH, where appropriate. Buffers and other reagents
were purchased from E. Merck, Darmstadt.
The MM isoenzyme of creatine kinase (ATP: creatine N phospho-
transferase, EC 2.7.3.2) was prepared according to Keutel et al.
(15) from rabbit and pig muscle and from human psoas muscle.
The BB isoenzyme of creatine kinase was isolated in crystalline
form from pig and human brain according to Atherton et al.
(16).
y-glutamyl transferase ((T-glutamyl)-peptide: amino-acid γ-glu*
tamyl-transferase, EC 2.3.2.2) was purified according to Orlowski
& Meister (17) using the modification of Richter (18) from
human and porcine kidneys.
Aspartate aminotransferase (I-Aspartate: 2-oxoglutarate amino-
transferase, EC 2.6.1.1), alanine aminotransferase (L-Alanine:
2-oxoglutarate aminotransferase, EC 2.6.1.2), H^isoenzyme
of lactate dehydrogenase (/,-Lactate: NAD oxidoreductase,
EC 1.1.1.27) and malate dehydrogenase (L-Malate: NAD oxi-
doreductase, EC 1.1.1.37) were separated from each other and
partially purified from human and porcine heart muscle in a
procedure related to the work of eisenherz et al. (19) on the
purification of rabbit muscle enzymes.
Aspartate aminotransferase (the cytoplasmic s-enzyme) and
alanine aminotransferase were further purified according to
(20,21).
For final purification of H4-isoenzyme of lactate dehydrogenase
and malate dehydrogenase we used methods as published by
Beisenherz et al. (19) and by Glatthaar et al. (22) respectively.
M4 isoenzyme of lactate dehydrogenase from human and
porcine muscle was crystallized according to (19).
The M4 and Η4 isoenzymes of lactate dehydrogenase were
separated from the other isoenzymes by chromatography using
DEAE cellulose; they each showed single bands in disk electro-
phoresis.
Glutamate dehydrogenase (I-Glutamate: NAD (P) oxidoreduc-
tase, EC 1.4.1.3) from human and ox liver was crystallized accord-
ing to Lehmann & Pfleiderer (23).
The specific activities of the purified enzymes are summarized
in table 1.
Enzyme activity assays were performed using an Eppendorf-
photometer, Model 1101 M, with automated cuvette changing
and scanning device. Wavelengths 365 nm and 405 nm; tempera-
ture 25 °C.
For protein determinations we used the biuret method (as cited
in 1. c. 8).'To get correct protein values for γ-glutamyl trans-
ferase it is necessary to complete the precipitation with trichlor-
acetic acid by heating (5 min, 95 °C).
The initial reaction velocity values for the determination of the
apparent Michaelis constants were obtained by starting the
reaction with appropriate enzyme dilutions, using substrate
concentrations in the suitable range in 1:2,1:4,1:8 etc. dilu-
tions. The assay conditions are stated below. The apparent
Am-values were derived from Lineweaver^Burk plots (24).
The optimum pH-values were determined with the assay condi-
tions described below. The pHkeadings were taken in the
cuvette immediately following the enzyme activity assay. All
assays for the same enzymes from different origins were per-
formed in series, by the same welltfained technician, using the
same instrumentation and reagents.
Results and Discussion
General Remarks
Purification
As can be seen from table 1 the final purity of the same
enzyme from different origins as expressed in specific
activity is in the same order of magnitude for all enzymes
studied. The same was true for the yield. With all of
these enzymes there was no problem in adapting the
purification procedures well-known to us for the
animals enzymes to the isolation of the human ones:
any purification step resulted in material of similar
specific activity in adequate yield. It may be concluded
that known differences in the protein structure of the
enzymes from different origins (to be discussed in 1. c.
(3)) are not important enough to interfere in the purifica-
tion procedures used.
Stability
All the enzyme preparations have now been stored at
4 °C for 2.5 years. (Aspartate aminotransferase, alanine
aminotransferase, lactate dehydrogenase (H4- and M4-
isoenzymes) and malate dehydrogenase as suspensions
in 3.2 mol/1 ammonium sulphate solution; glutamate
dehydrogenase as a solution in 50% aqueous glycerol;
creatine kinase and γ-glutamyl transferase as saltfree
lyophylates, γ-glutamyl transferase containing some
Triton X 100). The stability of the same enzyme from
different origins was shown to be of same magnitude
again, indicating further similarities of theoretical and
practical importance.
Creatine Kinase
The pH-optima and apparent A"m-values of the MM iso-
enzyme of creatine kinase from rabbit, porcine and
human psoas muscle are summarized in table 2; those
of the BB isoenzymes from the different brains are in
table 3.
Eor the determination of the creatine phosphofylation
we used conditions according to Tanzer & Gilvarg (25),
and for the reverse reaction we used those given by
Forster et al. (26). The conformity of figures for the
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Tab. 1. Comparison of the specific activity of the enzymes isolated from human and mammalian organs.
Enzyme
creatine kinase MM
MM
MM
BB
BB
7-glutamyl transf erase
Source
rabbit muscle
human psoas muscle
porcine muscle
human brain
porcine brain
human kidneys
porcine kidneys
U/mg protein
(25 °C)
250
315
251
286
328
20
20
Assay conditions (8)
triethanolamine buffer 0.1 mol/1, pH 7.0;
substrates:
creatine phosphate and A DP,
activation by glutathione,
continuous photometric registration at 365 nm.
Tris-buffer 185 mmol/1,
glycylglycine 40 mmol/1, pH 8.25;
7-glutamyl-4'-nitranilide 4 mmol/1,
continuous photometric registration at 405 nm.
aspartate aminotransf erase
alanine aminotransf erase
glutamate dehydrogenase
lactate dehydrogenase H4
H4
M4
M4
malate dehydrogenase
human heart
porcine heart
human heart
porcine heart
human liver
bovine liver
human heart
porcine heart
human psoas muscle
porcine muscle
210
200
78
80
250
190
375
360
395
450
human heart (cytoplasmic) 1060
porcine heart (cytoplasmic) 1100
phosphate buffer 80 mmol/1, pH 7.4,
substrates:
aspartate and 2-oxoglutaiate,
continuous photometric registration at 365 nm.
phosphate buffer 80 mmol/1, pH 7.4,
substrates:
L-alanine and 2-oxogiutarate,
continuous photometric registration at 365 nm.
imidazole buffer 85 mmol/1, pH 7.9,
substrates:
2-oxoglutarate and ammonia,
activation by ADP 2 mmol/1,
continuous photometric registration at 365 nm.
phosphate buffer 0,1 mol/1, pH 7.5,
substrate:
pyruvate,
continuous photometric registration at 365 nm.
phosphate buffer 0,1 .mol/1, pH 7.5,
substrate:
oxalo acetate,
continuous photometric registration at 365 nm.
same enzyme from different sources is sufficient, taking
into account the relatively low precision of the three-
fold coupled reaction (C. V. approx. 8 % in the range
studied) and a slight instability of the enzyme in the
very dilute solutions used (physiological sodium chloride
solution, no protein or thiol additives). Comparability
of apparent A"m-values can only be reached by using
exactly the same reaction conditions, as the two sub-
strates show an interdependence in both reaction
directions; there also occur product and salt inhibition,
dependency on magnesium ion versus nucleotide con-
centration ratios and so on. These were pointed out
for the MM isoenzyme (of rabbit muscle) by Morrison
et alf (27) and for the BB isoenzyme by Jacobs et al.
(28) and discussed by Watts (29). But by calculation
from their data (assayed at 30 °C) one can derive
figures for apparent K^ at similar concentrations
quite close to those stated here, e. g. for rabbit MM
isoenzyme of creatine kinase (27);
4.2 mmol/1creatine phosphate
adenosirie-5 '-diphosphate
creatine
adenosine-S^triphosphate
0.57 mmol/1
9.4 mmol/1
0.59 mmol/1
Data published by Szasz et al. (30) recently for appar-
ent ΑΊη-values for optimized conditions for creatine
kinase activity measurement in human sera differ con-
siderably, due to important differences in most of the
reaction parameters.
γ-Glutamyl Transpeptidase
γ-glutamyl transpeptidase preparations from kidneys
tend to aggregate in solutions not containing detergents
(31), giving rise to turbidities and loss of activity of the
soluble part. The data on pH-optima and apparent
Michaelis constants were therefore derived using enzyme
dilutions in Tris-buffer, 20 mmol/1, pH 8.25, containing
0,001% Triton XI00.
As shown in table 4 values for the human and porcine
preparations were absolutely identical.
The reaction conditions used were according to Szasz
(32). It is therefore not very surprising that the apparent
Km of 0.96 mmol/1 for Ι-γ-glutamyl-p-nitranilide as
determined by Szasz in patient sera is exactly the same
as ours. But these findings indicate catalytic similarities
J. Clin. Chem. Gun. Biochem. / Vol. 15,1977 / No. 10
568 Gruber, M llering and Perras: Isolation and properties of highly purified enzymes from human and animal sources
Tab. 2. Creatine kinase from muscle (CK-MM) - Apparent Michaelis constants and pH-optima - at 25 °C.
Rabbit
muscle
Porcine
muscle
Human psoas Assay conditions (Concentrations of constituents
muscle in the assay solution) (8)
Optimum pH 8.5
Substrate:
Creatine
Optimum pH 6.5
Substrate:
Creatine
Phosphate
App. Km
Creatine
App. Km
ATP
App. Km
Creatine
Phosphate
App. Km
ADP
8.8 8.5
7.0 6.5
11 mmol/1 11 mmol/1 15 mmol/1
480 Mmol/1 330 μηιοΐ/ΐ 440 μιηοΐ/ΐ
7.7 mmol/1 7.1 mmol/1 10 mmol/1
360 μιηοΐ/ΐ 330 μπιοΙ/1 500 μηιοΐ/l
glycine 0.45 mol/1; creatine 32 mmol/1;
ATP 1.2 mmol/1; NADH 0.2 mmol/1;
phosphoenol-pyruvate 0.4 mmol/1; M4 isoenzyme of
lactate dehydrogenase 28.5 mg/1 > 14 kU/1;
pyruvate kinase 28.5 mg/1 > 5.7 kU/1;
MgCl2 7 mmol/1.
triethanolamine 0.1 mol/1; glucose 20 mmol/1;
Mg-acetate 10 mmol/1; ADP 2 mmol/1;
creatine-phosphate 34 mmol/1; AMP 10 mmol/1;
NADP 0.6 mmql/1; glutathione 10 mmol/1;
hexokinase 7.4 mg/1 > 1.0 kU/1;
glucose-6-phosphate-dehydrogenase
7.4 mg/1 >1.0kU/l.
glycine 0.45 mol/1, pH 9.0; ATP 1.2 mmol/1;
NADH 0.2 mmol/1; phosphoenol-pyruvate 0.4 mmol/1;
MgCl2 7 mmol/1;
pyruvate kinase 28.5 mg/1 > 5.7 kU/1;
M4 isoenzyme of lactate dehydrogenase
28.5 mg/1 > 14 kU/L
glycine 0.45 mol/1, pH 9.0; creatine 32 mmol/1;
NADH 0.2 mmol/1; phosphoenol-pyruvate 0.4 mmol/1;
MgCl2 7 mmol/1;
pyruvate kinase 28.5 mg/1 > 5.7 kU/1;
M4 isoenzyme of lactate dehydrogenase
28.5 mg/1 > 14 kU/1.
triethanolamine 0.1 mol/1, pH 7.0; glucose 20 mmol/1;
magnesium acetate 10 mmql/1; ADP 2 mmol/1;
AMP 10 mmol/1; NADP 0.6 mmol/i;
glutathione 10 mmol/1; hexokinase 7.4 mg/1 > 1.0 kU/1;
glucose-6-phosphate^dehydrogenase
7.4 mg/1 >1.0kU/l.
triethanolamine 0.1 .mol/1, pH 7.0; glucose 20 mmol/1;
magnesium acetate 10 mmol/1;
creatine phosphate 34 mmoi/1; AMP 10 mmol/1;
NADP 0.6 mmol/1; glutathione 10 mmol/1;
hexokinase 7.4 mg/1 > 1.0 kU/1;
glucose-6-pliQSphate-dehydrogenase
7.4mg/l>1.0kU/l.
between the purified enzymes from kidney and the
liver enzyme, which is mainly present in patients' sera.
As the reaction mechanism of γ-glutamyl transferase
has been much less studied than that of the other
enzymes, the dependency of the apparent £m-values
on different reaction conditions is not quite clear.
Richter (33) found the Km for Ι-γ-glutamyl-p-nitranilide
to be 5.8 mmol/1 at 37 °C using tris-buffer, pH 9.0;
Miller et al. (31) defined a value of 0.8 mmol/1, (37 °C,
ammediol-buffer, pH 8.5.) The latter authors discuss
possible differences between the human and the hog
kidney enzyme, which were not found in the present
study.
Aspartate Aminotransferase
The figures shown in table 5 for pH-optima and
apparent Michaelis constants for cytoplasrilic s-enzyme
from human and porcine heart muscle are totally
identical. (The small discrepancy with 2-oxoglutarate is
within the experimental limits of error, CV 5 %). The
substrate concentrations chosen in the most commonly
used routine detection of oxaloacetate produced by
malate dehydrogenase coupling were similar to those
of K hnen et al. (34). For the assays in the opposite
reaction we detected the reaction product 2-ox glut r te
under appropriate conditions. As shown in recent
publications the reaction mechanism of aspartate mirio-
transferase is of the "ping-pong bi bi"-type (35) with
each substrate influencing the apparent Km of the paired
one in a mathematically distinct way (36,37, 38). The
dependency of A"m-values on small alterations in con-
centration of the second substrate is most important
under suboptimized conditions as used in this study.
The equalty of values shown for the preparations from
different sources is therefore quite indicative of their
catalytic similarity.
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Tab. 3. Creatine kinase from brain (CK-BB) - Apparent Rvalues and pH-optima - at 25 °C.
Porcine brain Human brain Assay conditions
(Concentrations of constituents in the assay solution) (8)
Optimum pH 9.0
Substrate:
Creatine
8.9 glycine 0.45 mol/1; creatine 32 mmol/1; ATP 1.2 mmol/1;
NADH 0.2 mmol/l> phosphoenol-pyruvate 0.4 mmol/1;
M4 isoenzyme of lactate dehydrogenase 28.5 mg/1 > 14 kU/1;
pyruvate kinase 28.5 mg/1 > 5.7 kU/1; MgCl2 7 mmol/1.
Optimum pH 6.7
Substrate:
Creatine
Phosphate
App. Km 1.4 mmol/1
Creatine
App. Km 140 μηιο1/1
ATP
App. Km 4.0 mmol/1
Creatine
phosphate
App. Km 300 μιηοΐ/ΐ
ADP
6.7 triethanolamine 0.1 mol/1; glucose 20 mmol/1;
magnesium-acetate 10 mmol/1; ADP 2 mmol/1;
creatine phosphate 34 mmol/1; AMP 10 mmol/1; NADP 0.6 mmol/1;
glutathione 10 mmol/1; hexokinase 7.4 mg/1 > 1.0 kU/1;
glucose-6-phosphate-dehydrogenase 7.4 mg/1 > 1.0 kU/1.
1 .5 mmol/I glycine 0.45 mol/1, pH 9.0; ATP 1 .2 mmol/1; NADH 0.2 mmol/1;
phosphoenol-pyruvate 0.4 mmol/1; MgCla 7 mmol/1;
pyruvate kinase 28.5 mg/1 > 5.7 kU/1;
M4 isoenzyme of lactate dehydrogenase 28.5 mg/1 > 14 kU/1.
190 Mmol/l glycine 0.45 mol/l, pH 9.0; creatine 32 mmol/1; NADH 0.2 mmol/1;
phosphoenol-pyruvate 0.4 mmol/1; MgCl2 7 mmol/1;
pyruvate kinase 28.5 mg/J > 5.7 kU/1;
M4 isoenzyme of lactate dehydrogenase 28.5 mg/1 > 14 kU/1.
5.7 mmol/1 triethanolamine 0.1 mol/1, pH 7.0; glucose 20 mmol/1;
magnesium acetate 10 mmol/1; ADP 2 mmol/1; AMP 10 mmol/1;
NADP 0.6 mmol/1; glutathione 10 mmol/1;
hexokinase 7.4 mg/1 > 1.0 kU/l;
glucose-6-phosphate-dehydrogenase 7.4 mg/1 > 1.0 kU/1.
300 μπιοΐ/ΐ triethanolamine 0.1 mol/1, pH 7.0; glucose 20 mmol/1;
magnesium acetate 10 mmol/1; creatine phosphate 34 mmol/1;
AMP 10 mmol/1; NADP 0.6 mmol/1; glutathione 10 mmol/1;
hexokinase 7.4 mg/1 > 1.0 kU/1;
glucose-6-phosphate-dehydrogenase 7.4 mg/1 > 1.0 kU/1.
Tab. 4. γ-Glutamyl-transpeptidase from kidneys - Apparent A"m-values and pH optima - at 25 °C.
Porcine kidney Human kidney Assay conditions
(Concentrations of constituents in the assay solution) (8)
Optimum pH 8.2 8.2 Tris-buffer 0.2 mol/1; γ-glutamy ' ^tranilide 4 mmol/1;
glycylglycine 40 mmol/1.
Αρρ.ΑΊη 1.0 mmol/1
γ-glutamyl-
p-nitroanilide
App. Km
glycyl-glycine
1.0 mmol/1 Tris-buffer, pH 8.25, 0.2 mol/i, ^
33 mmol/1 33 mmol/1 Tris-buffer, pH 8.25, 0.2 mol/1; τ-glutamyl-p-nitroanilide 4 mmol/1.
In addition we checked the reactivation of both aspartate
aminotransferase preparations by pyridoxal phosphate.
The coenzyme can be completely removed in the pyri-
doxamine form from the apoenzyme by incubation
with aspartate followed by dialysis at pH 5 (39). Both
resulting apoenzyme preparations had zero tr nsamina-
tion activity. Upon incubation with pyridoxal phosphate
activity was fully restored (95-100% of original) within
l min. Even in this respect the human and porcine
enzyme behaved completely similarly.
Similar equivalence between highly purified aspartate
aminotransferase from human erythrocytes and our
pig heart preparation were reported byRef (37), who
also gave figures for true.Arm-values for human m- and
s-enzyme.
Alanine Aminotransferase
Table 6 shows the correspondence between pH-optima
and apparent Km-values for alanine aminotransferase
preparations from pig and human heart muscle, as was
found for the aspartate aminotransferase preparations.
Conditions chosen for the routinely used direction with
detection of the pyruvate produced were again sub-
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Tab. 5. Aspartate aminotransferase (cytoplasmic) from heart - Apparent ATm-values and pH-optima - at 25 °C.
Pig heart Human heart Assay conditions
(Concentrations of constituents in the assay solution) (8)
Optimum pH 8.0-8.5
Substrate:
aspartate
Optimum pH 7.1
Substrate:
glutamate
6.2 mmol/1
Z-aspartate
App.A"m 400 μηιο1/1
2-oxoglutarate
App. Km
oxaloacetate
App. Km
I-glutamate
91 μπιοΙ/1
6.7 mmol/1
8.0-8.3 phosphate buffer 81 mmol/1; 1-aspartate 32.5 mmol/1;
2-oxoglutarate 6.75 mmol/1; NADH 0.16 mmol/1;
M4 isoenzyme of lactate dehydrogenase 4.15 mg/I > 2.08 kU/1;
malate dehydrogenase 4.15 mg/1 > 4.6 kU/L
7.1 triethanolamine 90 mmol/l; I-glutamate 50 mmpl/1;
oxaloacetate 1 mmol/1; NADH 0.2 mmql/1; ammonium acetate 106 mmol/l;
glutamate dehydrogenase 67 mg/1 > 6.0 kU/L
6.2 mmol/1 phosphate buffer pH 7.4,81 mmol/1; 2-pxoglutarate 6.75 mmol/1;
NADH 0.16 mmol/1;
M4 isoenzyme of lactate dehydrogenase 4.15 mg/1 > 2.08 kU/1;
malate dehydrogenase 4.15 mg/1 > 4.6 kU/1.
500 Mmol/1 phosphate buffer pH 7.4, 81 mmol/1; Ζ,-aspart te 32.5 mmol/1;
NADH 0.16 mmol/1;
M4 isoenzyme of lactate dehydrogenase 4.15 mg/1 > 2.08 kU/1;
malate dehydrogenase 4.15 mg/1 > 4.6 kU/1.
91 MmoVl triethanolamine pH 8.0, 87 mmol/1; NADH 0.2 mmol/1;
I-glutamate 48 mmol/1; ammonium acetate 106 mmol/1;
glutamate dehydrogenase 333 mg/1 > 30 kU/1.
6.7 mmol/1 triethanolamine pH 8.0, 87 mmol/1; oxaloacetate 2.6 mmol/1;
NADH 0.2 mmol/1; arnmprimm acetate 106 mmol/1;
glutamate dehydrogenase 333 mg/1 > 30 kU/1.
Tab. 6. Alanine aminotransferase from heart - Apparent ^-values and pH optima - at 25 °C.
Porcine heart Human heart Assay conditions
(Concentrations of constituents in the assay solution) (8)
Optimum pH
Substrate:
alanine
Optimum pH
Substrate:
glutamate
App. Km
I -alanine
7.9-8.1
7.6
28 mmol/1
7.9-8.1
7.6
28 mmol/1
phosphate buffer 81 mmol/1; D, ^ alanine 65 mmol/1; NADH 0.16 mmol/1;
2-oxoglutarate 6.75 mmol/l;
M4 isoenzyme of lactate dehydrogenase 4.15 mg/1 > 2.08 kU/1.
triethanolamine 90 mmol/1; L-glutamate 50 mmol/1; pyruvate 2.2 mmol/1;
NADH 0.2 mmol/1; ammonium acetate 106 mmol/1;
glutamate dehydrogenase 67 mg/1 > 6.0 kU/L
phosphate buffer pH 7.4, 81 mmol/1; NADH 0.16 mmol/1;
2-oxoelutarate 6.75 mmol/1:
App. Km 400 Mmol/1
2-oxoglutarate
App. Km
L-glutamate
App. Km
pyruvate
10 mmol/1
200 Mmol/1
M4 isoenzyme of lactate dehydrogeriase 4.15 mg/1 > 2.08 kU/L
290 Mmol/1 phosphate buffer pH 7.4, 81 mmol/1; D, Lralanirie 65 mfhol/1;
NADH 0.16 mmol/1;
M4 isoenzyme of lactate dehydrogenase 4.15 mg/1 > 2.08 kU/L
12 mmol/1 triethanolamine pH 8.0, 87 mmol/1; pyruvate 2.12 mmol/1;
NADH 0.2 mmol/l; ammonium acetate 106 mmol/1;
glutamate dehydrogenase 333 mg/1 > 30 kU/1.
200 Mmol/1 triethanolamine pH 8.0, 90 mmol/1; ^glutamate 50 rhmol/1;
NADH 0.2 mmol/l; ammonium acetate 106 mmol/1;
glutamate dehydrogenase 67 mg/1 ^  6.0 kU/1.
optimal, according to 1. c. (40). As in the assay of
aspartate aminotransferase, we used a glutamate dehy-
drogenase-linked system for the opposite direction,
and measured the production of 2-oxoglutarate.
The reaction mechanism of alanine aminotransferase
is less studied than that of aspartate aminotransferase,
but it seems to follow the same order (41) with similar
inter-dependencies of optimum concentrations for the
paired substrates. Thus for alanine aminotransferase the
equality of the determined values is again a strong
indication of the similarity of the catalytic sites of both
preparations.
In contrast to aspartate aminotrapsferase there are no
simple possibilities known for the removal of the co-
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enzyme in either form from alanine aminotransferase
preparations. Our experiments directed to the isolation
of apoenzymes were also without success. Upon addi-
tion of pyridoxal phosphate to our purified alanine
aminotransferase preparations we,observed inactivation
of both enzymes, depending to the same degree on the
concentration of coenzyme added, and following the
same time course.
Glutamate Dehydrogenase
The similarity of crystalline glutamate dehydrogenase
preparations from human and beef liver in respect of
pH-optima and apparent Km-values as shown in table 7
is again sufficient. Deviations are at the most two-fold,
which is not meaningful for practical use of the beef
enzyme for replacement of human glutamate dehydro-
genase in control materials.
The assay conditions chosen for the routinely used
reaction in the direction of glutamate production were
according to E. Schmidt (42). This method includes
the activation of glutamate dehydrogenase by adenosine-
S'-diphosphate, reported by Frieden (43). For the oppo-
site direction of glutamate dehydrogenation we used
arbitrary, suboptimal conditions to get possibly a better
discrimination between the human and the animal
enzyme. In the determination of the apparent Km for
NAD+ we encountered problems with substrate inhibi-
tion.
The mechanism of the glutamate dehydrogenase has
been extensively studied (for review see Smith et al.
(44)). Substrates and coenzyme were shown to be bound
in an at least partly random manner to the enzyme (45).
The evaluation of true Km-values (different ones for
the different enzyme complexes) is further complicated
by the allosteric properties of the enzyme (46).
Lehmann &Pfleiderer (23) isolated glutamate dehydro-
genase from human liver in a slightly different way and
compared their crystalline enzyme with our beef liver
preparation. Their data on the human enzyme are very
close to ours.
Lactate Dehydrogenase
Our data on the pH-optima and apparent A"m-values for
the H4- and the M4-isoenzymes isolated from human
and porcine material are shown in table 8. The agree-
ment of the data obtained for the H4-preparations is
excellent. There are slight discrepancies for the M4-iso-
enzymes from both sources, the human enzyme showing
lower affinity for pyruvate, higher for lactate as compared
to the porcine enzymes.
The assay conditions for pyruvate reduction are those of
Bergmeyer et al. (47), for lactate dehydrogenation
according toAmador et al. (48).
The mechanism of lactate dehydrogenase catalysis was
shown to comprise a compulsory order of coenzyme
and substrate binding to the enzyme (for review see
1. c. (49)). The dissociation of the reacted coenzyme is
rate limiting. Due to inhibitive and subunit-cooperative
effects apparent Km-values with this enzyme again are
quite dependent on reaction conditions.
Comparitive studies on purified lactate dehydrogenase
isoenzymes from different sources have been performed
by several laboratories (e. g. Pesce et al. (50) and Wachs-
Tab. 7. Glutamate dehydrogenase from liver - Apparent /Tm-values and pH optima - at 25 °C.
Bovine liver Human liver Assay conditions(Concentrations of constituents in the assay solution) (8)
Optimum pH 7.75
Substrate:
2-oxoglutarate
Optimum pH 8.4
Substrate:
glutamate
7.75
8.3
triethanolamine 31 mmol/1; ADP 1 mmol/1; EDTA 2.5 mmol/1;
NADH 0.19 mmol/1; 2-oxoglutarate 6.4 mmol/1;
ammonium acetate 100 mmol/1.
phosphate buffer 83 mmol/1; EDTA 3.3 mmol/1; NAD 0.5 mmol/1;
Z,-glutamate 4.5 mmpl/1.
App. A"
2-oxoglutarate
App K
NADHm
App. KIR
ammonia
App.tfm
glutamate
App, KmNAlD
5.0 mmol/1
100 μηιοΙ/1
16 mmol/1
1.5 mmol/1
appr.
product
2.9 mmol/1
200 μηιοΐ/l
16 mmol/1
1.2 mmol/1
appr.
100 μηιοΙ/1
inhibition
triethanolamine pH 8.0, 31 mmol/1; EDTA 2.5 mmol/1; ADP 1 mmol/1;
NADH 0.19 mmol/1; ammonium acetate 100 mmol/1.
triethanolamine pH 8.0, 31 mmol/1; EDTA 2.5 mmol/1; ADP 1 mmol/1;
ammonium acetate 100 mmol/1; 2-oxoglutarate 6.4 mmol/L
triethanolamine pH 8.0, 31 mmol/1; EDTA 2.5 mmol/1; ADP 1 mmol/1;
K DH 0.19 mmol/1; 2-oxoglutarate 6.4 mmol/1.
phosphate buffer pH 7.5, 83 mmol/1; EDTA 3.3 mmol/1; NAD 0.5 mmol/1.
phosphate pH 7.5, 83 mmol/1; EDTA 3.3 mmol/1; L-glutamate 4.5 mmol/1.
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Tab. 8. Lactate dehydrogenase from heart and muscle (LDH-H4 and LDH-M4) - Apparent X"m-values and pH optima - at 25 °C.
Human heart Porcine heart Human muscle Porcine muscle Assay conditions (Concentration
H4 isoenzyme H4 isoenzyme M4 isoenzyme M4 isoenzyme of constituterits in the
assay solution) (8)
Optimum pH 7.5
Substrate:
pyruvate
Optimum pH 8.5-8.7
Substrate:
lactate
7.5
8.5-8.7
6.6-7.5
8.5-8.7
7.5
8.5-8.7
phosphate buffer 50 mmol/1;
pyruvate 0.6 mmol/1;
NADH 0.18 mmol/1.
phosphate buffer 46 mmol/1;
NAD 0.5 mmol/1;
I-lactate 34 mmol/1.
App. Km
pyruvate
App. Km
NADH
App. Km
L-lactate
App. Km
NAD
140
10
4.5
63
M-noVl
MmoVl
mmoVl
MmoVl
150
11
3.3
67
Mmol/1
Mmol/1
mmol/1
MmoVl
500
11
4.5
110
MmoVl
MmoVl
mmol/1
Mmol/1
120 MmoVl
12 MmoVl
8.3 mmol/1
100 MmoVl
phosphate buffer pH 7.5,
50 mmoVl; NADH 0.18 mmol/1.
phosphate buffer pH 7.5,
50 mmol/1; pyruvate 0.6 mmoVl.
phosphate buffer pH 7.5,
46 mmol/1; NAD 0.5 mmol/1.
phosphate buffer pH 7.5,
46 mmoVl; I-lactate 34 mmol/l.
muth &Pfleiderer (51). The latter group focussed their
extensive studies on human isoenzymes from different
organs (52,53). Their overall results correspond to our
data. Ernes et al. (54) crystallized the HU-isoenzyme
from human heart muscle. Their apparent Km -value
for pyruvate of 102 μτηοΐ/ΐ is in close agreement with
ours.
Malate Dehydrogenase
Results on pH-optima and apparent Km -values of
mitochondrial malate dehydrogenase are reported in
table 9. The enzyme preparations from human and
porcine heart muscle are completely identical in these
respects.
Malate dehydrogenase is only in minor use in Clinical
Chemistry now. The conditions used for oxaloacetate
reduction were according to Bergmeyer et al. (55);
arbitrary conditions were used for malate dehydrogena-
tion.
The mechanism of catalysis by malate dehydrogenase
is of a similar compulsory order type to that of lactate
dehydrogenase (56). The usefulness of apparent Micha&
Us constants is limited in the same way, but their close
agreement under the same conditions again indicates a
similarity between the catalytic sites of the human and
porcine enzyme.
We have found no comparison data for human malate
dehydrogenase nor on the purification of the enzyme
from human heart. But the values found for the pig
heart preparation in this study are in the same range as
reported by Grimm (57).
Tab. 9. Malate dehydrogenase - Apparent ATm-values and pH optima - at 25 °C.
Porcine heart Human heart Assay conditions
(Concentration of constituents in the assay solution) (8)
Optimum pH 8.3 8.4
Substrate:
oxaloacetate
Optimum pH 10.0-10.5 10.0-10.5
Substrate:
malate
phosphate buffer 95 mmol/ί; oxaloacetate 0.5 mmol/1; NADH 0.2 mmol/1.
glycine buffer 95 mmol/1; L-malate 120 mmol/1; NAD 4.4 mmol/L
App. Km 33 Mmol/1
oxaloacetate
App. Km 50 MmoVl
NADH
App. A"m 500 MmoVl
Z-malate
App. "m 250 Mmol/1
NAD
33 MmoVl phosphate buffer pH -8.3, 95 mmoVl; NADH 0.2 mmoVl.
50 Mmol/1 phosphate buffer pH 8.3, 95 mmoVl; oxaloacetate 0.5
400 Mmol/1 glycine pH 10.0, 95 mmol/1; NAD 4.4 mmol/1.
250 MmoVl glycine pH 10.0, 95 mmoVl; L^malate 120 mmol/1.
mmoVl.
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